NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Allison A Johnson
i
Virginia Commonwealth University - Richmond / United States
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 1346762
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Allison A Johnson's MOST POPULAR ARTICLES
1-)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative GroupLancet (London, England) 397 (10285), 1637, 20211708*2021
2-)
International incidence of childhood cancer, 2001–10: a population-based registry studyE Steliarova-Foucher, M Colombet, LAG Ries, F Moreno, A Dolya, F Bray, ...The Lancet Oncology 18 (6), 719-731, 201716212017
3-)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trialsRC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ...The Lancet Oncology 21 (2), 271-282, 202010262020
4-)
Integrase inhibitors to treat HIV/AIDSY Pommier, AA Johnson, C MarchandNature reviews Drug discovery 4 (3), 236-248, 200510032005
5-)
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specificationsP Yilmaz, R Kottmann, D Field, R Knight, JR Cole, L Amaral-Zettler, ...Nature biotechnology 29 (5), 415-420, 20117612011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept